or Try an Advanced Search...

    Treatment Of Glaucoma Stocks List

    Symbol Grade Name % Change
    GKOS A Glaukos Corporation 3.03
    STAA B STAAR Surgical Company -2.76
    OCUL D Ocular Therapeutix, Inc. 5.91
    ACAD D ACADIA Pharmaceuticals Inc. 2.03
    LXRX F Lexicon Pharmaceuticals, Inc. 7.14
    INM F InMed Pharmaceuticals Inc. 0.69
    BLCO F Bausch + Lomb Corporation -5.50
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Glaucoma Cataract Surgery Cataracts Eye Vision Biopharmaceutical Clinical Trial Cornea Eye Surgery Incision Medicine Ocular Hypertension Ophthalmology Allergic Conjunctivitis Allergology Alzheimer's Disease Aspheric Lens Astigmatism Biotie Therapies Blindness

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Glaucoma stocks.

    Symbol Grade Name Weight
    AWEG D Alger Weatherbie Enduring Growth ETF 7.87
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 6.41
    XHE C SPDR S&P Health Care Equipment 4.14
    BBP C BioShares Biotechnology Products Fund 3.73
    IBRN C iShares Neuroscience and Healthcare ETF 3.32
    View all Treatment Of Glaucoma ETFs...
    Compare ETFs
    Compare PSCH to BBP Compare PSCH to IBRN Compare XHE to IBRN

        Treatment Of Glaucoma Stocks Recent News

        Date Stock Title
        May 1 OCUL Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
        May 1 STAA STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
        Apr 30 GKOS Glaukos Q1 2024 Earnings Preview
        Apr 30 GKOS Can the 4 Medical Device Stocks Hit Targets This Earnings Season?
        Apr 29 ACAD Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
        Apr 29 LXRX Lexicon Pharmaceuticals announces retirement of CEO Lonnel Coats
        Apr 29 LXRX Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals
        Apr 29 STAA STAAR Surgical to Report First Quarter Results on May 7, 2024
        Apr 29 LXRX Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024
        Apr 29 BLCO Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 ACAD ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago
        Apr 25 STAA Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Glaucoma Cataract Surgery Cataracts Eye Vision Biopharmaceutical Clinical Trial Cornea Eye Surgery Incision Medicine Ocular Hypertension Ophthalmology Allergic Conjunctivitis Allergology Alzheimer's Disease Aspheric Lens Astigmatism Biotie Therapies Blindness
        Treatment Of Glaucoma

        Treatment of glaucoma depends on the type and severity of the condition. Treatment options may include medications, laser surgery, or traditional surgery. Medications may include eye drops, pills, or injections. Laser surgery may be used to reduce intraocular pressure and improve fluid drainage. Traditional surgery may involve creating a new drainage channel for fluid to escape the eye.

        Browse All Tags